Related Experiment Video
Updated: Jun 14, 2025
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Evolving and Improving the Sustainability of Molecular Tumor Boards: The Value and Challenges
Marius Bartels1, Benoist Chibaudel2, Rodrigo Dienstmann3,4,5
1Department of Medical Oncology, Praxis für Onkologie Mönchengladbach, 41066 Mönchengladbach, Germany.
Abstract:
The increasing volume of information for cancer care, and the evolution of molecularly guided therapies, have increased the need for molecular tumor boards (MTBs), which can integrate such data into personalized treatment plans to improve patient outcomes. However, recommendations for improving the sustainability of MTBs are lacking. A diverse committee of MTB experts was assembled (February-March 2023), with extensive experience in sustainability in healthcare ecosystems. The aim was to identify MTB-related hurdles throughout the patient journey and develop a general framework for MTBs to operate on larger scales locally, nationally, and internationally. The committee identified ten key pillars for sustainable and scalable MTBs, including technical solutions for data integration and visualization, interoperability, learning loops, clinical trial access, legal considerations, criteria for patient testing, decision standardization, making MTBs official bodies for treatment decisions, local leaders, and international networks. The need for scalable frameworks at academic and community levels was recognized, along with integrating MTBs into national health systems to enhance sustainability and ensure optimal treatment decisions. Irrespective of the health ecosystem, the sustainability and scalability of MTBs are essential. Our framework provides guidelines to address this and to help MTBs evolve towards integrated, essential components of the oncology healthcare system.
Insights
Molecular tumor boards (MTBs) are crucial for personalized cancer care but lack sustainability guidelines. This framework outlines ten pillars to ensure MTBs can scale effectively for improved patient outcomes.
Area of Science:
- Oncology
- Genomics
- Healthcare Management
Background:
- The increasing complexity of cancer care and molecularly guided therapies necessitates robust molecular tumor boards (MTBs).
- Existing MTBs face challenges in sustainability and scalability, hindering their widespread implementation and impact on patient outcomes.
- There is a critical need for standardized frameworks to guide the development and operation of sustainable MTBs.
Framework:
- A comprehensive framework for sustainable and scalable MTBs has been developed, addressing key operational pillars.
- Ten essential pillars include technical data integration, interoperability, learning loops, clinical trial access, legal aspects, patient testing criteria, decision standardization, official decision-making status, local leadership, and international collaboration.
- This framework aims to facilitate the integration of MTBs into academic, community, and national healthcare systems.
Implementation:
- The framework addresses hurdles across the patient journey to enable MTBs to operate at local, national, and international scales.
- It emphasizes the importance of technical solutions for data management and visualization to support complex treatment decisions.
- Integration into national health systems is proposed as a key strategy for enhancing MTB sustainability and ensuring optimal oncology care.
Implications:
- Sustainable and scalable MTBs are essential for delivering personalized cancer treatment, irrespective of the healthcare ecosystem.
- The proposed framework provides actionable guidelines for evolving MTBs into integral components of the oncology healthcare system.
- Implementing these guidelines will support improved patient outcomes through more effective and accessible molecularly guided therapies.
